4//SEC Filing
Sherblom James 4
Accession 0001062993-23-000610
CIK 0001907685other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:15 PM ET
Size
9.1 KB
Accession
0001062993-23-000610
Insider Transaction Report
Form 4
Sherblom James
Director
Transactions
- Award
Warrants (right to buy)
2023-01-04$0.25/sh+81,081$20,270→ 81,081 totalExercise: $1.23From: 2023-01-04Exp: 2028-01-04→ Common Stock (162,162 underlying) - Award
Common Stock
2023-01-04$1.23/sh+81,081$99,730→ 452,244 total
Footnotes (2)
- [F1]The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 81,081 units (the "Units") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the "Common Stock"), and one warrant (the "Warrants") to purchase two shares of Common Stock (the "Warrant Shares") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules.
- [F2]The exercisability of the Warrants is subject to a 9.99% beneficial ownership limitation.
Issuer
Comera Life Sciences Holdings, Inc.
CIK 0001907685
Entity typeother
Related Parties
1- filerCIK 0001926230
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:15 PM ET
- Size
- 9.1 KB